| Literature DB >> 27190599 |
Hayato Fukuda1, Saki Ito1, Kenji Watari2, Chihiro Mogi3, Mitsuhiro Arisawa1, Fumikazu Okajima3, Hitoshi Kurose2, Satoshi Shuto4.
Abstract
GPR4, a pH-sensing G protein-coupled receptor, is highly expressed in endothelial cells and may be activated in myocardial infarction due the decreased tissue pH. We are interested in GPR4 antagonists as potential effective pharmacologic tools and/or drug leads for the treatment of myocardial infarction. We investigated the structure-activity relationship of a known GPR4 antagonist 1 as a lead compound to identify 3b as the first potent and selective GPR4 antagonist, whose effectiveness was demonstrated in a mouse myocardial infarction model.Entities:
Keywords: GPR4; dibenzazepine derivatives; myocardial infarction; pH-sensing GPCR
Year: 2016 PMID: 27190599 PMCID: PMC4867472 DOI: 10.1021/acsmedchemlett.6b00014
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345